vs
Side-by-side financial comparison of NCR Atleos Corp (NATL) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
NCR Atleos Corp is the larger business by last-quarter revenue ($1.2B vs $622.0M, roughly 1.9× Royalty Pharma plc). Royalty Pharma plc runs the higher net margin — 34.4% vs 7.2%, a 27.2% gap on every dollar of revenue. On growth, Royalty Pharma plc posted the faster year-over-year revenue change (4.8% vs 4.0%). Over the past eight quarters, NCR Atleos Corp's revenue compounded faster (4.9% CAGR vs 4.6%).
NCR Voyix Corporation, previously known as NCR Corporation and National Cash Register, is a global software, consulting and technology company providing several professional services and electronic products. It manufactured self-service kiosks, point-of-sale terminals, automated teller machines, check processing systems, and barcode scanners.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
NATL vs RPRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2B | $622.0M |
| Net Profit | $83.0M | $214.2M |
| Gross Margin | — | — |
| Operating Margin | 13.5% | 62.4% |
| Net Margin | 7.2% | 34.4% |
| Revenue YoY | 4.0% | 4.8% |
| Net Profit YoY | 102.4% | 2.9% |
| EPS (diluted) | $1.09 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.2B | $622.0M | ||
| Q3 25 | $1.1B | $609.3M | ||
| Q2 25 | $1.1B | $578.7M | ||
| Q1 25 | $979.0M | $568.2M | ||
| Q4 24 | $1.1B | $593.6M | ||
| Q3 24 | $1.1B | $564.7M | ||
| Q2 24 | $1.1B | $537.3M | ||
| Q1 24 | $1.0B | $568.0M |
| Q4 25 | $83.0M | $214.2M | ||
| Q3 25 | $26.0M | $288.2M | ||
| Q2 25 | $39.0M | $30.2M | ||
| Q1 25 | $14.0M | $238.3M | ||
| Q4 24 | $41.0M | $208.2M | ||
| Q3 24 | $21.0M | $544.0M | ||
| Q2 24 | $27.0M | $102.0M | ||
| Q1 24 | $-9.0M | $4.8M |
| Q4 25 | 13.5% | 62.4% | ||
| Q3 25 | 9.8% | 70.1% | ||
| Q2 25 | 10.8% | 36.3% | ||
| Q1 25 | 9.5% | 94.0% | ||
| Q4 24 | 13.4% | 60.9% | ||
| Q3 24 | 10.6% | — | ||
| Q2 24 | 9.8% | 50.2% | ||
| Q1 24 | 6.5% | -13.0% |
| Q4 25 | 7.2% | 34.4% | ||
| Q3 25 | 2.3% | 47.3% | ||
| Q2 25 | 3.5% | 5.2% | ||
| Q1 25 | 1.4% | 41.9% | ||
| Q4 24 | 3.7% | 35.1% | ||
| Q3 24 | 2.0% | 96.3% | ||
| Q2 24 | 2.5% | 19.0% | ||
| Q1 24 | -0.9% | 0.8% |
| Q4 25 | $1.09 | $0.49 | ||
| Q3 25 | $0.34 | $0.67 | ||
| Q2 25 | $0.52 | $0.07 | ||
| Q1 25 | $0.19 | $0.55 | ||
| Q4 24 | $0.56 | $0.46 | ||
| Q3 24 | $0.28 | $1.21 | ||
| Q2 24 | $0.37 | $0.23 | ||
| Q1 24 | $-0.13 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $456.0M | $618.7M |
| Total DebtLower is stronger | $2.7B | $9.0B |
| Stockholders' EquityBook value | $403.0M | $9.7B |
| Total Assets | $5.7B | $19.6B |
| Debt / EquityLower = less leverage | 6.63× | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $456.0M | $618.7M | ||
| Q3 25 | $412.0M | $938.9M | ||
| Q2 25 | $357.0M | $631.9M | ||
| Q1 25 | $352.0M | $1.1B | ||
| Q4 24 | $419.0M | $929.0M | ||
| Q3 24 | $395.0M | $950.1M | ||
| Q2 24 | $374.0M | $1.8B | ||
| Q1 24 | $343.0M | $843.0M |
| Q4 25 | $2.7B | $9.0B | ||
| Q3 25 | $2.8B | $8.9B | ||
| Q2 25 | $2.8B | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $2.9B | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
| Q4 25 | $403.0M | $9.7B | ||
| Q3 25 | $330.0M | $9.6B | ||
| Q2 25 | $350.0M | $9.5B | ||
| Q1 25 | $275.0M | $9.8B | ||
| Q4 24 | $219.0M | $10.3B | ||
| Q3 24 | $264.0M | $10.3B | ||
| Q2 24 | $250.0M | $9.8B | ||
| Q1 24 | $283.0M | $9.9B |
| Q4 25 | $5.7B | $19.6B | ||
| Q3 25 | $5.7B | $19.3B | ||
| Q2 25 | $5.8B | $18.3B | ||
| Q1 25 | $5.7B | $17.6B | ||
| Q4 24 | $5.5B | $18.2B | ||
| Q3 24 | $5.7B | $18.0B | ||
| Q2 24 | $5.8B | $17.7B | ||
| Q1 24 | $5.8B | $16.1B |
| Q4 25 | 6.63× | 0.92× | ||
| Q3 25 | 8.45× | 0.93× | ||
| Q2 25 | 8.05× | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | 13.05× | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $231.0M | $827.1M |
| Free Cash FlowOCF − Capex | $194.0M | — |
| FCF MarginFCF / Revenue | 16.8% | — |
| Capex IntensityCapex / Revenue | 3.2% | — |
| Cash ConversionOCF / Net Profit | 2.78× | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | $239.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $231.0M | $827.1M | ||
| Q3 25 | $25.0M | $702.6M | ||
| Q2 25 | $-23.0M | $364.0M | ||
| Q1 25 | $123.0M | $596.1M | ||
| Q4 24 | $80.0M | $742.5M | ||
| Q3 24 | $107.0M | $703.6M | ||
| Q2 24 | $9.0M | $658.2M | ||
| Q1 24 | $148.0M | $664.6M |
| Q4 25 | $194.0M | — | ||
| Q3 25 | $-5.0M | — | ||
| Q2 25 | $-44.0M | — | ||
| Q1 25 | $94.0M | — | ||
| Q4 24 | $62.0M | — | ||
| Q3 24 | $85.0M | — | ||
| Q2 24 | $-14.0M | — | ||
| Q1 24 | $124.0M | — |
| Q4 25 | 16.8% | — | ||
| Q3 25 | -0.4% | — | ||
| Q2 25 | -4.0% | — | ||
| Q1 25 | 9.6% | — | ||
| Q4 24 | 5.6% | — | ||
| Q3 24 | 7.9% | — | ||
| Q2 24 | -1.3% | — | ||
| Q1 24 | 11.9% | — |
| Q4 25 | 3.2% | — | ||
| Q3 25 | 2.7% | — | ||
| Q2 25 | 1.9% | — | ||
| Q1 25 | 3.0% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 2.1% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | 2.3% | — |
| Q4 25 | 2.78× | 3.86× | ||
| Q3 25 | 0.96× | 2.44× | ||
| Q2 25 | -0.59× | 12.06× | ||
| Q1 25 | 8.79× | 2.50× | ||
| Q4 24 | 1.95× | 3.57× | ||
| Q3 24 | 5.10× | 1.29× | ||
| Q2 24 | 0.33× | 6.45× | ||
| Q1 24 | — | 139.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATL
| Services | $848.0M | 74% |
| APJ | $136.0M | 12% |
| Americas Excluding United States | $135.0M | 12% |
| TT | $44.0M | 4% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
